Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UDIBI CAR-T cell therapy
- Development stage
- Preclinical
- Lead developer
- UDIBI
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Administration
- Intravenous
01
Overview
UDIBI CAR-T cell therapy is an experimental chimeric antigen receptor (CAR) T-cell therapy being developed by the Unidad de Desarrollo e Investigación en Bioprocesos (UDIBI) at the Instituto Politécnico Nacional (IPN) in Mexico. Currently in the preclinical research phase, this program focuses on engineering T cells to target and eliminate malignant cells in leukemia. As a research line within UDIBI's pipeline, specific details regarding the CAR construct, such as the target antigen or the signaling domains used, have not been publicly specified. The project represents part of Mexico's efforts to develop indigenous cell therapy platforms for hematological cancers.
- Other names
- Terapia celular CAR-T (UDIBI-IPN)CAR-T cell therapy-UDIBI-IPN-cell therapy (CAR-T)-Leukemia (suspected)
Beyond the preview
Go deeper on UDIBI CAR-T cell therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UDIBI CAR-T cell therapy.